The Colton Center for Autoimmunity, University of Pennsylvania
banner
penncoltoncenter.bsky.social
The Colton Center for Autoimmunity, University of Pennsylvania
@penncoltoncenter.bsky.social
Our mission is to apply bold, collaborative, translational science to advance our mechanistic understanding of human autoimmunity. Proudly part of the @coltonconsortium.bsky.social‬.

Learn more: www.med.upenn.edu/penncoltoncenterautoimmunity
Reposted by The Colton Center for Autoimmunity, University of Pennsylvania
Join us Nov. 18 for the Colton Consortium Virtual Speaker Series! Hear from David Hafler, MD, FANA (@yaleschoolofmed.bsky.social) a leader in #neuroimmunology, on the gut–brain axis in homeostasis and disease. Registration required: bit.ly/HaflerNov18
November 10, 2025 at 3:26 PM
E. John Wherry, PhD, reflected on a conversation with his friend—and new Nobel laureate—Fred Ramsdell, PhD, about the future of #autoimmunity research. Ramsdell’s advice to “stay focused on foundational research” is guiding the direction of Penn’s Colton Center for Autoimmunity. bit.ly/471uuKQ
Penn is expanding its research in immunology — a field just honored with a Nobel Prize
E. John Wherry, director of Penn's Colton Center for Autoimmunity, spoke with the Inquirer about the future of immunology research at Penn and the new $376 million research facility.
www.inquirer.com
October 22, 2025 at 2:56 PM
Last week, Dr. Wherry showed Good Morning Philadelphia around Penn Medicine's new collaborative research hub for #immunology, #immunehealth, and #autoimmunity, including the new home of the Penn Colton Center for Autoimmunity. Watch the interview: https://www.fox29.com/video/1707836
Penn Medicine Opens $376M Immunology Center Boosting Research in Philadelphia
New Penn Medicine center houses hundreds of researchers testing treatments for autoimmune conditions.
www.fox29.com
September 22, 2025 at 2:08 PM
Have you registered yet for next week's session (9/16, 11AM ET) of the #ColtonConsortium Virtual Speaker Series featuring Mark Anderson, MD, PhD (USCF + @ucsfdc.bsky.social)? Dr. Anderson will address "Dissection of #Autoimmunity Through Outliers." Registration required: bit.ly/AndersonSept16
September 9, 2025 at 6:26 PM
We're thrilled to share space in Penn Medicine's new collaborative research hub for #immunology, #immunehealth, and #autoimmunity — working with remarkable labs and leaders to advance scientific breakthroughs that benefit patients' lives.
Last week, Penn Medicine leaders cut the ribbon on a new home for #immunology research. The eight-story "overbuild" at 3600 Civic Center Blvd will house I3H, #ImmuneHealth, @penncoltoncenter.bsky.social, and related areas to foster interdisciplinary collaboration.

▶️ Watch: youtu.be/Ryv2AxPtb_E?...
Building Upon Excellence: Penn’s New Collaborative Research Hub
YouTube video by Penn Medicine
youtu.be
September 8, 2025 at 6:35 PM
Katalin Susztak, MD, PhD, and team developed #AI tools and datasets—like the SISKA atlas and CellSpectra—to map 70+ kidney cell types. This advances precision medicine with the potential to reveal new insights into immune-mediated kidney disease. bit.ly/4mSH0lk
Penn-developed AI tools and datasets help tailor treatments for kidney patients | Penn Today
Penn Medicine and Wharton researchers have partnered to create CellSpectra and SISKA, offering clues to better treatments for kidney disease and beyond.
bit.ly
September 5, 2025 at 7:25 PM
Don't miss the next installment (9/16, 11AM ET) of the #ColtonConsortium Virtual Speaker Series featuring Mark Anderson, MD, PhD (UCSF + @ucsfdc.bsky.social), a leader in #diabetes and #autoimmunity research. Registration required: bit.ly/AndersonSept16
September 4, 2025 at 3:28 PM
The 2025 Colton Consortium Symposium brought together leaders, researchers, and partners from Penn, NYU, Yale, and Tel Aviv University to share their scientific breakthroughs and plan the next advances in autoimmune disease research.

🔎 Check out our recap: www.coltonconsortium.org/blog/inside-...
August 13, 2025 at 7:21 PM
Earlier this year, the Colton Center for Autoimmunity at @pennmedicine.bsky.social launched two new Centers of Excellence to advance autoimmune diagnostics and treatment—deepening its impact through the @coltonconsortium.bsky.social. Learn more about the missions of HIT-AI and CREATE: bit.ly/4kRTJCT
Colton Center for Autoimmunity Consortium - Main
bit.ly
July 24, 2025 at 7:37 PM
Congratulations to Sahily Reyes-Esteves, MD, PhD (@sahilyreyes.bsky.social), Assistant Professor of Neurology and Colton Center awardee, and our other Penn Medicine (@pennmedicine.bsky.social) colleagues on being selected for a McCabe Fund Award! 🏆
Congratulations to this year's @pennmedicine.bsky.social McCabe Fund Awardees! @PennRheum @PennRadOnc @PennRadiology #Dermatology @pennsurgery.bsky.social @PennNeurology @Penn_DFMCH @PennPulmonary @dbei-upenn.bsky.social @chopresearch.bsky.social @PennVet tinyurl.com/546y5nmc
July 24, 2025 at 6:45 PM
Genetic screening may have unlocked a path for treating the severe inflammation associated with many immune diseases by regulating one protein’s role in helping another protein control cell acidity, according to recent research published in Cell by the @minerlab.bsky.social. bit.ly/43Hw6HK
Controlling cell acidity could be key to autoimmune disease | Penn Medicine
Genetic screening may have unlocked a path for treating severe inflammation in autoimmune disease by regulating proteins controlling cell acidity.
www.pennmedicine.org
May 21, 2025 at 5:38 PM
Big news out of @pennmedicine.bsky.social: @davidfajgenbaum.bsky.social, @jbrandmdphd.bsky.social, and colleagues have identified Oligocentric Castleman Disease (OligoCD)—the first new Castleman subtype in 45 years. This discovery has the potential to reshape diagnosis and care for thousands.
For the first time in 45 years, a new subtype of Castleman disease has been identified, allowing patients to receive the right treatment for their condition ft. @davidfajgenbaum.bsky.social (@pennmedicine.bsky.social) & @jbrandmdphd.bsky.social (@penncancer.bsky.social) tinyurl.com/52mjd9az
May 21, 2025 at 5:23 PM
Congrats @davidfajgenbaum.bsky.social on being named to the TIME100 Health 2025 list! After being diagnosed with Castleman disease, he found an existing drug that saved his life. Now he’s using AI to repurpose FDA-approved drugs—offering hope to others with hard-to-treat conditions. bit.ly/4kdkgdX
TIME100 Health: David Fajgenbaum
Find out why David Fajgenbaum is on the TIME100 Health 2025 list.
bit.ly
May 21, 2025 at 5:19 PM
150+ experts came together at the 2025 Penn Colton Center for #Autoimmunity Symposium to discuss breakthroughs in #ImmuneHealth and spotlight Penn’s leadership, future headquarters, and innovations in autoimmunity research and #PrecisionMedicine.

Read more: www.coltonconsortium.org/blog/2025-pe...
May 20, 2025 at 3:11 PM